BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11848018)

  • 1. [Changes in mammography and breast ultrasonography in women undergoing hormonal replacement therapy].
    Rzymski P; Szpakowska-Rzymska I; Wilczak M; Warenik-Szymankiewicz A; Sajdak S
    Ginekol Pol; 2001 Oct; 72(10):809-15. PubMed ID: 11848018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change in the glandular bodies of the breast after hormone therapy. Observations from the radiologic viewpoint].
    Lendvai-Viragh K; Ritzkowsky D
    Aktuelle Radiol; 1994 Sep; 4(5):264-7. PubMed ID: 7986847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy.
    Harvey JA
    AJR Am J Roentgenol; 1999 Jun; 172(6):1615-9. PubMed ID: 10350301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The HRT follow-up consultation. What to do in case of breast tumour (clinical or radiological) and microcalcifications. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Mathelin C; Molière S
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):485-492. PubMed ID: 33757919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
    Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
    Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRT and breast changes.
    Whyte K
    Aust Fam Physician; 2001 Nov; 30(11):1084,1089. PubMed ID: 11770487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
    McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
    AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal replacement therapy and breast cancer. A case-control study].
    Basavilvazo Rodríguez MA; Díaz Quiroz A; Lemus Rocha R; Angeles Victoria L; Zárate A; Hernández-Valencia M
    Ginecol Obstet Mex; 2004 Jan; 72(1):10-5. PubMed ID: 15239559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.
    Cahn MD; Tran T; Theur CP; Butler JA
    Am Surg; 1997 Oct; 63(10):858-60. PubMed ID: 9322657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme.
    Litherland JC; Evans AJ; Wilson AR
    Clin Radiol; 1997 Apr; 52(4):276-9. PubMed ID: 9112944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographically detected breast arterial calcifications: indicators for arteriosclerotic diseases?
    Taşkin F; Akdilli A; Karaman C; Unsal A; Köseoğlu K; Ergin F
    Eur J Radiol; 2006 Nov; 60(2):250-5. PubMed ID: 16890393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of increased mammographic breast density response to hormone replacement therapy.
    Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
    Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and breast density changes.
    Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
    Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy and breast cancer].
    Dobashi K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
    Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
    Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
    Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
    Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy, proliferation in the breast and risk of carcinoma].
    Strnad P; Rob L; Zuntová A; Moravcová Z; Chod J; Halaska M
    Ceska Gynekol; 2002 Nov; 67(6):337-43. PubMed ID: 12661372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.